-
1.发明授权Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness 失效单不饱和脂肪作为膳食补充剂，以尽量减少分解代谢疾病的影响
公开(公告)号：US5260336A
公开(公告)日：1993-11-09
申请号：US876189
申请日：1992-04-30
IPC分类号： A23L1/30 , A61K31/20 , A61K31/201 , A61K31/23 , A61K31/685 , A61K36/18 , A61P3/00 , A61P3/06 , A61P9/00 , C07C69/58 , A61K31/22
摘要： Disclosed is a method of minimizing the effects of a catabolic illness in an individual by administering to the individual a diet which is controlled in the type of fatty acid intake. The diet comprises an oil rich in .omega.9 monounsaturated fatty acids, preferably oleic acid. Oils rich in monounsaturated fatty acids include olive oil, canola oil and high oleic acid safflower or high oleic acid sunflower oil. The diet can also be administered to an individual to minimize infection or to minimize the risk of infection in the individual. A dietary supplement useful in methods of the invention and a structured lipid are also disclosed.
摘要翻译： 公开了一种通过向个体施用以脂肪酸摄入类型控制的饮食来最小化分解代谢疾病对个体的影响的方法。 饮食包含富含ω9单不饱和脂肪酸的油，优选油酸。 富含单不饱和脂肪酸的油包括橄榄油，菜籽油和高油酸红花或高油酸向日葵油。 也可以向个体施用饮食以最小化感染或将个体感染的风险降至最低。 还公开了可用于本发明方法和结构化脂质的膳食补充剂。
-
2.发明授权Parenteral dietary supplement and method of minimizing effects of infection through diet 失效胃肠外营养补充剂和减少通过饮食感染影响的方法
公开(公告)号：US4820731A
公开(公告)日：1989-04-11
申请号：US207122
申请日：1988-06-15
IPC分类号： A61K31/20 , A23L33/00 , A61K31/047 , A61K31/23 , A61K35/60 , A61K36/00 , A61K36/28 , A61K36/48 , A61K38/00 , A61P31/04 , A61P31/12 , A61P33/10 , A61P37/00 , A61P43/00 , A61K31/22
摘要： Disclosed is a method of minimizing infection and minimizing the risks of infection in at risk animals and patients. A dietary supplement to accomplish this objective is also disclosed. The method includes the step of administering a diet rich in .omega.3 fatty acids, for example by adding a substantial proportion of fish oils to the diet. The dietary supplement is particularly well suited to patients receiving total parenteral nutrition. A parenteral diet or diet supplement containing a mixture of oils, one rich in .omega.3 fatty acids and the other rich in .omega.6 fatty acids is disclosed.
摘要翻译： 公开了一种最小化感染并最大限度地减少危险的动物和患者的感染风险的方法。 也披露了实现这一目标的膳食补充剂。 该方法包括施用富含ω3脂肪酸的饮食的步骤，例如通过将相当大比例的鱼油加入到饮食中。 膳食补充剂特别适合于接受全肠外营养的患者。 公开了含有富含ω-3脂肪酸和其它富含ω-6脂肪酸的油的混合物的肠胃外饮食或饮食补充剂。
-
3.发明授权
公开(公告)号：US4871768A
公开(公告)日：1989-10-03
申请号：US92438
申请日：1987-09-03
IPC分类号： A61K31/20 , A23D9/007 , A23L1/29 , A23L1/30 , A61K31/047 , A61K31/23 , A61K31/685 , A61K35/60 , A61K36/00 , A61K36/28 , A61K36/48 , A61K38/00 , A61P3/06 , A61P31/04 , A61P31/12 , A61P33/10 , A61P37/00 , A61P43/00 , C07C69/587 , C11C3/10
摘要： A new dietary supplement has been developed which yields the benefits of both .omega.3 oils and medium chain triglycerides for lipid nutrition. A structured lipid containing .omega.3 fatty acids and medium chain fatty acids is also disclosed.
摘要翻译： 已经开发了一种新的膳食补充剂，其产生了ω-3油和中链甘油三酯用于脂质营养的益处。 还公开了含有ω3脂肪酸和中链脂肪酸的结构化脂质。
-
公开(公告)号：US4752618A
公开(公告)日：1988-06-21
申请号：US630732
申请日：1984-07-12
IPC分类号： A61K31/20 , A23L33/00 , A61K31/047 , A61K31/23 , A61K35/60 , A61K36/00 , A61K36/28 , A61K36/48 , A61K38/00 , A61P31/04 , A61P31/12 , A61P33/10 , A61P37/00 , A61P43/00 , A61K31/335
摘要： Disclosed is a method of minimizing infection and minimizing the risks of infection in at risk animals and patients. A dietary supplement to accomplish this objective is also disclosed. The method includes the step of administering a diet rich in .omega.3 fatty acids, for example by adding a substantial proportion of fish oils to the diet. The dietary supplement is particularly well suited to patients receiving total parenteral nutrition.
摘要翻译： 公开了一种最小化感染并最大限度地减少危险的动物和患者的感染风险的方法。 也披露了实现这一目标的膳食补充剂。 该方法包括施用富含ω3脂肪酸的饮食的步骤，例如通过将相当大比例的鱼油加入到饮食中。 膳食补充剂特别适合于接受全肠外营养的患者。
-
-
-
搜索结果
4 条记录 (耗时 0.014 秒)
